G1 Therapeutics, Inc.
Antiproliferative pyrimidine-based compounds

Last updated:

Abstract:

This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

Status:
Grant
Type:

Utility

Filling date:

21 Dec 2018

Issue date:

19 May 2020